Who Paid My Doc
Panhematin
Drug Metabolic Agent
NDC 55292-702-55
General payments
$235,345
Research payments
$9,999
Through program year 2025, $235,345 in general payments and $9,999 in research payments were reported against Panhematin (Metabolic Agent).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
5 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $134,482 | 267 |
| 2025 | Research | $9,999 | 1 |
| 2024 | General | $67,734 | 120 |
| 2023 | General | $2,847 | 157 |
| 2022 | General | $30,281 | 90 |
Breakdown
The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.
The top 5 of 31 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
The top 5 of 29 states; each share is of general payments naming this product in 2025 where a state was reported.
Records
634 general · 1 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.